 GERMANTOWN, Md., Dec. 7, 2020 PRNewswire -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced at the 62nd ASH Annual Meeting and Exposition Abstract 2864 clinical progress... 